Summary & Overview
CPT 78227: Hepatobiliary Scintigraphy for Liver-Bile-Gallbladder Imaging
CPT code 78227 represents hepatobiliary scintigraphy — a nuclear medicine imaging study that tracks bile production and flow to evaluate the liver, bile ducts, and gallbladder. The exam is clinically important for diagnosing bile duct obstruction or leakage, cholecystitis, gallstones, and other hepatobiliary disorders. It frequently involves administration of a medication to enhance diagnostic yield.
This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the service line, typical sites of care, and how the procedure is coded for national billing. The publication also provides benchmarking insights, common modifier usage, and policy or coverage considerations that affect payment and utilization across payers.
Intended for revenue cycle leaders, clinical managers, and policy analysts, the content outlines what to expect when billing CPT code 78227, summarizes payer coverage patterns, and highlights operational points relevant to ordering, scheduling, and claims submission. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 78227 describes a diagnostic imaging procedure, also known as hepatobiliary scintigraphy, in which the provider images the liver, bile, bile ducts, and gallbladder to follow the production and flow of bile from the liver to the small intestine. The exam is used to diagnose bile duct obstruction or leakage, abnormalities in the bile ducts, cholecystitis (gallbladder inflammation), gallstones, and other disorders affecting the hepatobiliary system. In this study the provider administers medication to help obtain a diagnosis.
Service type: Nuclear medicine hepatobiliary imaging with pharmacologic intervention
Typical site of service: Hospital outpatient radiology/nuclear medicine department or freestanding imaging center
Clinical & Coding Specifications
Clinical Context
A 52-year-old patient presents to nuclear medicine with right upper quadrant abdominal pain, intermittent fever, and mildly elevated liver function tests after a recent hospitalization for suspected gallbladder disease. The clinician orders hepatobiliary scintigraphy to evaluate gallbladder function and to detect cystic duct obstruction, acute cholecystitis, biliary leak, or bile duct obstruction. The patient is screened for contraindications to radiopharmaceuticals and fasting requirements; an IV line is placed and a technologist injects the hepatobiliary radiotracer. Dynamic imaging is performed over the liver, gallbladder, bile ducts, and small bowel. If study interpretation requires pharmacologic stimulation (for example, administration of cholecystokinin to assess gallbladder ejection fraction or morphine to enhance biliary ductal visualization), the provider administers the medication per protocol and continues imaging. Images are interpreted by a nuclear medicine physician, a report is generated describing tracer uptake, hepatic excretion, gallbladder visualization, ejection fraction if measured, and any signs of obstruction or leak. Results guide next-step management such as surgical consultation for cholecystectomy, endoscopic or radiologic evaluation of bile ducts, or conservative medical care.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing physician interpretation separate from technical component |